{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Avidity Biosciences, Inc."},"Symbol":{"label":"Symbol","value":"RNA"},"Address":{"label":"Address","value":"10578 SCIENCE CENTER DRIVE,SUITE 125, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 401-7900"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.aviditybiosciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Sarah Boyce","title":"President, Chief Executive Officer & Director"},{"name":"Steven G. Hughes","title":"Chief Medical Officer"},{"name":"W. Michael Flanagan","title":"Chief Scientific & Technical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}